Different Roles of p38 MAPK and ERK in STI571-Induced Multi-Lineage Differentiation of K562 Cells

Journal of Cellular Physiology

Volumn 198, Issue 3, 2004, Pages 370-376

  Kohmura, Kanoko ^a   Miyakawa, Yoshitaka ^a   Kawai, Yoko ^a   Ikeda, Yasuo ^a   Kizaki, Masahiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTIGEN; BIOLOGICAL MARKER; CD11B ANTIGEN; CD42 ANTIGEN; ENZYME INHIBITOR; FIBRINOGEN RECEPTOR; GLYCOPHORIN A; HEMOGLOBIN; IMATINIB; MESSENGER RNA; MICROSOMAL AMINOPEPTIDASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PIPERAZINE DERIVATIVE; PRIMER DNA; PROTEIN C MYB; PYRIMIDINE DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CELL COUNT; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; DEPHOSPHORYLATION; DRUG EFFECT; ENZYME PHOSPHORYLATION; ERYTHROID CELL; HEMATOPOIESIS; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MEGAKARYOCYTE; METABOLISM; ONCOGENE C MYB; PHOSPHORYLATION; PHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BIOLOGICAL MARKERS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINEAGE; DNA PRIMERS; ENZYME INHIBITORS; HEMOGLOBINS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; K562 CELLS; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-MYB; PYRIMIDINES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 1242317094     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10426     Document Type: Article

References (22)

1. Bellon T, Perrotti D, Calabretta B. 1997. Granulocytic differentiation of normal hematopoietic precursor cells induced by transcription factor PU.1 correlates with negative regulation of the c-myb promoter. Blood 90:1828-1839.
2. Deininger MW, Goldman JM, Lydon N, Melo JV. 1997. The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells. Blood 90:3691-3698.
3. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB. 1996. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2:561-566.
4. Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M. 2001. Activity of a specific inhibitor of BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with Philadelphia chromosome. N Engl J Med 344:1038-1042.
5. Efimova T, Broome AM, Eckert RL. 2003. A regulatory role for p38 delta MAPK in keratinocyte differentiation: Evidence for p38 delta-ERK1/2 complex formation. J Biol Chem 278:34277-34285.
6. Fang G, Kim CN, Perkins CL, Ramadevi N, Winton E, Wittmann S, Bhalla KN. 2000. CGP57148B (STI571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs. Blood 96:2246-2253.
7. Fukuchi Y, Kizaki M, Yamato K, Kawamura C, Umezawa A, Hata Ji, Nishihara T, Ikeda Y. 2001. Mcl-1, an early-induction molecule, modulates activin A-induced apoptosis and differentiation of CML cells. Oncogene 20:704-713.
8. Gesbert F, Griffin JD. 2000. Bcr/Abl activates transcription of the Bcl-X gene through STAT5. Blood 96:2269-2276.
9. Griffin JD. 2002. Resistance to targeted therapy in leukaemia. Lancet 359:458-459.
10. Hu Y, Chan E, Wang SX, Li B. 2003. Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation. Endocrinology 144:2068-2074.
11. Karafiat V, Dvorakova M, Pajer P, Kralova J, Horejsi Z, Cermak V, Bartunek P, Zenke M, Dvorak M. 2001. The leucine zipper region of Myb oncoprotein regulates the commitment of hematopoietic progenitors. Blood 98:3668-3876.
12. Kizaki M, Matsushita H, Takayama N, Muto A, Ueno H, Awaya N, Kawai Y, Asou H, Kamada N, Ikeda Y. 1996. Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid resistant features. Blood 88:1824-1833.
13. Matsumura I, Kawasaki A, Tanaka H, Sonoyama J, Ezoe S, Minegishi N, Nakajima K, Yamamoto M, Kanakura Y. 2000. Biologic significance of GATA-1 activities in Ras-mediated megakaryocytic differentiation of hematopoietic cell lines. Blood 96:2440-2450.
14. Miyata Y, Nishida E. 1999. Distantly related cousins of MAP kinase: Biochemical properties and possible physiological functions. Biochem Biophys Res Commun 266:291-295.
15. Nagata Y, Todokoro K. 1999. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood 94:853-863.
16. Nagata Y, Takahashi N, Davis RJ, Todokoro K. 1999. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 92:1859-1869.
17. Park JI, Choi HS, Jeong JS, Han JY, Kim IH. 2001. Involvement of p38 kinase in hydroxyurea-induced differentiation of K562 cells. Cell Growth Differ 12:481-486.
18. Rojnuckarin P, Miyakawa Y, Fox NE, Deou J, Daum G, Kaushansky K. 2001. The roles of phosphatidylinositol 3-kinase and protein kinase Czeta for thrombopoietin-induced mitogen-activated protein kinase activation in primary murine megakaryocytes. J Biol Chem 6:41014-41022.
19. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, Hunt T, Nebreda AR. 1994. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78:1027-1037.
20. Thiesing JT, Ohno-Jones S, Kolibaba KS, Druker BJ. 2000. Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-abl-positive cells. Blood 96:3195-3199.
21. Weisberg E, Griffin JD. 2000. Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL-transformed hematopoietic cell lines. Blood 95:3498-3505.
22. Witt O, Sand K, Pekrun A. 2000. Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood 95:2391-2396.